Ima Winner Fund Club: Dodge & Cox Stock Fund
Value funds dominate the bestseller list these days, so now is a good time to separate the Vonnegut from the, well, Grisham.
| Related Stories |
| I Own What?! Value Funds That Look Like Banks |
| The Big Screen: 10 Smaller Value Funds You Can't Afford to Ignore |
| Ima Winner Fund Club: Dodge & Cox Stock Fund |
| 10 Questions With Janus Growth & Income's David Corkins |
Value types' thrifty approach kept them out of the sizzling tech sector in 1999, when the average large-cap value fund gained just 7%, compared with 41% for its average growth peer. But their modest tech appetite is paying off now, with big-cap value funds down just 1% over the past 12 months, compared with a 38% free fall for their growth competitors, according to Chicago fund-tracker Morningstar. We advocate owning both growth and value funds to diversify your portfolio because they tend to flourish in different environments. Until recently, growth funds were gobbling up the vast majority of money flowing into stock funds. Now the trend has reversed, but in picking a value fund it's still important to be choosy, as a look at our new winner and loser will clearly show.
The Winner
If the hallmarks of a great fund are long-tenured managers, above-average gains, below-average volatility and a low-trading, tax-efficient style, look no further than the Dodge & Cox Stock fund. A team of eight managers runs this 36-year-old fund, and nearly all have been in place for at least 15 years. Very simply, they invest in stocks of mid- and large-cap companies they think are trading for less than their true worth and merit holding for years. That might sound vanilla, but it has paid off in a big way. The fund tops at least 96% of its peers and the S&P 500 over the past one, three, five and 10 years. It has also been remarkably consistent, beating the category average in eight of the past 10 years and posting just two down years since 1980.| Ima Winner |
| Source: Morningstar. Returns through Aug. 21. |
| Past Winners |
| Large-Cap Growth: Growth Fund of America |
| Mid-Cap Growth: Bridgeway Aggressive Growth |
| Tech: Dresdner RCM Global Technology |
| Health Care: Vanguard Health Care |
The Grisham
The Seligman Common Stock fund's defenders might say it's just misunderstood, but they don't really have a leg to stand on.| Past Losers |
| Large-Cap Growth: Putnam New Opportunities |
| Mid-Cap Growth: Putnam OTC & Emerging Growth |
| Tech: T. Rowe Price Science & Technology |
| Health: Invesco Health Sciences |
| Ima Loser |
| Source: Morningstar. Returns through Aug. 21. |
- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,291.26 | 1,098.51 | 2,166.90 | 34.74 |
Oil *
77.90
|
|
UP
44.29
|
UP
5.50
|
UP
15.82
|
DOWN
0.08
|
10 Yr
3.47%
SPDR Gold
109.60
|
|
+0.43%
|
+0.50%
|
+0.74%
|
-0.23%
|
Data delayed 20 minutes |














